2C-B No Longer a Research Chemical

No Comments

Erowid, widely considered to be a forefront authority on information regarding recreational drug use, have recently removed their classification of 2C-B as a research chemical. Research chemicals are generally considered as being drugs which have relatively little history of human use, and also have little associated research pertaining to toxicity or other potential dangers.

2C-B itself was first synthesised by Alexander Shulgin in 1974, and was initially highly popular as a literal 'research chemical,' in the field of psychiatric treatment. It was favoured over other psychedelics for such research because of its short duration and relatively mild level of intensity.

Following a similar pattern to LSD and psilocybin, its medical use led to recreational use - becoming an early and prominent example of a 'designer drug,' seeing a large rise in popularity in the US club scene following the illegalisation of MDMA in 1985. The replacement made sense, due to 2C-B being similarly empathogenic while remaining relatively mild in psychedelic effects, which might be considered too disinhibiting for a party environment; many users describe the experience as a 'lesser roll.'

Its initial grounding in medical research, relatively early adoption as a recreational chemical, along with its history of being sold as an aphrodisiac in Germany means that it actually has a rather lengthy history of use; time has shown the drug to be relatively safe, in line with many other drugs in the psychedelic class.

It was specifically banned in the United States in 1994, and later placed on the international Convention on Psychotropic Substances register in 2000 - despite previous research into its therapeutic benefit and an abject failure to cite any sources associating the drug with potential harm to users.

'Research Chemical' can be a rather abstract term, but today applies more readily to the legion of brand new substances becoming immediately available for recreational use on the Internet - suffering a total lack of initial research in any medical context or any history of human use.

Read more about 2C-B on the TripSit Wiki!